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EVALUATION OF ARTIFACTS IN EXPERIMENTAL 4D CT ACQUISITION
METHODS

by

Sarah Joy Castillo, M.S.

Supervisory Professor: Thomas Guerrero, M.D., Ph.D.

Four-dimensional computed tomography (4D CT) has increased the accuracy of radiation
treatment planning for patients in whom the extent of target motion is large. 4D CT has
become a standard of care for radiation treatment simulation, allowing decreased motion
artifacts and increased spatiotemporal localization of anatomical structures that move.
However, motion artifacts may still remain. These artifacts, or artificial anatomic spatial
distributions, add a systematic uncertainty to the treatment process and limit the accuracy
of lung function images derived from CT. We proposed to reduce the motion artifacts in
cine 4D CT by using three novel investigational 4D CT acquisition methods: (1)
oversampling the data acquired, (2) gating the x-ray beam with breathing irregularities,
and (3) rescanning areas of the clinical standard 4D CT associated with high breathing
irregularities. These experimental acquisitions were tested through a protocol approved
by the institutional review board with 18 patients with a primary thoracic malignancy
receiving a standard 4D CT scan for radiation treatment simulation. The artifact presence
in all 4D CT scans was assessed by an automated artifact quantification metric. This
artifact metric was validated by a rigorous receiver operating characteristic (ROC)
analysis using a high-quality dataset derived from a group of expert observers who
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reached a consensus decision on the artifact frequency and magnitude for each of 10
clinical 4D CT scans from patients with primary thoracic cancer. The clinical and
experimental 4D CT acquisitions from the 18 patients on the protocol were postprocessed by the clinical standard of phase sorting and by an experimental phase sorting
that incorporated the validated artifact metric. The 4D CT acquisition and processing
method judged to be the most improved was the oversampling acquisition with the
experimental sorting. The reproducibility of this improved method was tested on a second
distinct cohort of 10 patients with a primary thoracic malignancy. Those patients received
a clinical phase-sorted 4D CT immediately followed by three independent oversampling
acquisitions, processed by the experimental sorting method and evaluated using the
artifact metric. The experimental-sorted oversampling acquisition produced a statistically
significant artifact reduction (27% and 28% per cohort) from the phase-sorted clinical
standard acquisition.
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CHAPTER 1
BACKGROUND & INTRODUCTION
MOTIVATION
Four-dimensional computed tomography (4D CT) is routinely employed as an
integral part of radiation therapy simulation when there is a need to account for
respiratory motion.(1-7) 4D CT relates the image acquisition with the patient’s breathing
resulting in a series of 3D image volumes that represent the breathing cycle from peak
inhalation through exhalation to peak inhalation.(8, 9) This method enables more accurate
treatment delivery by limiting the uncertainty in the target cancer location as the target
deforms with respiratory motion.(5,

10, 11)

However, the ability of the 4D CT to limit

uncertainties associated with anatomic position depends on image quality.
Artifacts, or artificial anatomic spatial distributions, cause uncertainty in the true
anatomic spatial distribution that lead to errors in anatomic delineation, treatment
targeting, and lung function images derived from CT. 4D CT may contain both standard
3D CT artifacts and those specific to the 4D acquisition and mode. Artifacts specific to
4D CT often arise from breathing irregularities that are currently not accounted for in the
clinical setting. These irregularities may introduce appreciable artifacts into the images,
and the only recourse to using the low-quality dataset for treatment planning is to reacquire a clinical 4D CT scan. If the re-acquired 4D CT demonstrates appreciable
artifacts, free-breathing images that do not contain these artifacts are used for treatment
planning. These images do not account for respiratory motion, and represent multiple
breathing states within one 3D CT.
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To the best of our knowledge, methods to prospectively reduce 4D CT image
artifacts by altering the acquisition have not been attempted in a clinical setting. In the
present study, we implemented three experimental 4D CT acquisition methods that target
breathing irregularities (acquiring more images, gating the x-ray beam with breathing
irregularities, and re-acquiring images associated with breathing irregularities) in patients
with thoracic cancer to determine the potential for improving 4D CT image quality in a
clinical setting in a relatively simple manner. Unlike in most previous studies, the
methods we used focused on acquisition modification rather than retrospective analysis.

4D CT PROCESS
4D CT is a common motion-management method used in radiation treatment
simulation. The American Association of Physicists in Medicine (AAPM) recommends
the use of a motion management simulation method in the presence of anatomic motion
that exceeds 5 mm in any direction,(6) which occurs in about 40% of lung targets.(12)
Because thoracic and some abdominal structures meet this motion threshold, 4D CT has
become the standard protocol for patients scheduled to undergo radiation treatment for
thoracic cancer at The University of Texas MD Anderson Cancer Center.
The 4D CT images are used as the primary dataset for the radiation treatment plan;
target and normal tissue contours are delineated and defined on the primary dataset.
Radiation fields and beam arrangements are designed based on the contours to achieve
target coverage and normal tissue dose constraints. Anatomic uncertainty arising from the
4D CT primary dataset will propagate into the treatment plan and delivery as a systematic
uncertainty and will increase the difference between the planned and the delivered dose.
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I. Respiratory Characterization
4D CT typically relies on an external motion surrogate to capture breathing
information that is independent of the image acquisition. In the most common
setup, an abdominal belt or a real-time processing monitor (RPM) box is placed on
top of the patient’s abdomen between the xiphoid process and umbilicus. The
surrogate records a 1-dimensional signal of either relative mechanical pressure
(belt) from a pressure sensor or relative abdominal height from infrared reflective
dots on the box (RPM); this 1D signal represents the patient’s respiratory trace.
These two external surrogates have found to be equivalent systems in terms of
image quality and effect on treatment planning,(13-15) but they have also been found
to exhibit good but not exact correlation with internal anatomic motion.(16-19)
A 4D CT scan comprises a set of 3D CT scans; each 3D CT image set
represents a phase of the breathing cycle as defined from peak inhalation through
exhalation to peak inhalation on the external surrogate respiratory trace. Thus each
voxel must be imaged for at least one breathing cycle or phase representations will
be inaccurate. Peak inhalation positions are first computationally defined by
smoothing the waveform and finding the local maxima; then they are reviewed by
the user and re-defined if a false peak was computationally selected.
Breathing phases may be defined by even divisions in the breathing period
(time between peaks of a cycle), by five even divisions in time between the initial
peak inhalation and the peak exhalation and five even divisions in time between
peak exhalation and the final inhalation, or by five even divisions in abdominal
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displacement between the initial peak inhalation and the peak exhalation and five
even divisions in abdominal displacement between peak exhalation and the final
inhalation. The number of breathing phases per cycle is user-defined, but typically
set at 10. Generating fewer breathing phases may ensure non-overlapping data and
quicker delineation times while generating more breathing phases leads to potential
overlap in data (using the same images in multiple phases) and longer delineation
times. The choice of 10 phases also derives from sampling requirements, as a
typical breathing cycle lasts five seconds and current 4D-capable CT scanners have
roughly a 0.5 second tube rotation time.
Secondary image sets are often derived from the 4D CT breathing phases;
most commonly derived are the maximum intensity projection (MIP), a 3D CT
consisting of the maximum pixel intensities present in the phases, and the average
(AVG), composed of the mean pixel intensities present in the phases.

II. 4D CT Modes
Two modes of 4D CT are currently clinically available: helical and cine. The
breathing aspects of 4D CT remain the same for each implementation, but the
image acquisition and post-processing differ significantly.
i) Helical 4D CT
Helical CT is currently the most commonly used mode of 3D CT in
diagnostic imaging because of its high efficiency and the ability to reconstruct
images at any point along the patient’s cranial-caudal ( ) direction. Slip rings
enable the efficiency by allowing a continuous x-ray tube rotation for the scan

4

duration. The reconstruction ability derives from how the data are acquired; the xray tube is rotating while the table below the patient moves, creating a helical
photon projection. Data are then interpolated so that a continuous data set exists,
allowing image reconstruction at any  plane. The pitch is defined as the table
motion per 360 degree tube rotation,  divided by the collimated beam
width,

(Eqn. 1.1). Typical diagnostic pitch values range from 0.75 to 1.5, with

1.0 allowing data acquisition for full anatomy without overlap.(20)
 


(1.1)

In 4D CT, the acquisition process remains the same, but the pitch is
lowered, typically less than 0.1, so that each voxel is imaged for at least one
breathing cycle.(21-23) Images are reconstructed for all breathing phases and
binned. The interpolation and continuous acquisition of data in helical 4D CT
results in artifacts that seem to vary more smoothly (Figure 1.2) in a particular
location compared with cine artifacts. The appearance of lines will often occur if a
breathing irregularity occurred and a voxel was not sampled for a full breathing
cycle.(23)

ii) Cine 4D CT
Cine 4D CT derives from the axial mode of diagnostic CT, which
acquires images in collimated beam width size segments along the cranial-caudal
direction while the table is stationary. This “step-and-shoot” method requires a
cine duration input rather than a pitch to specify the time duration of image
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acquisition at each couch step for data sufficiency. At MD Anderson Cancer
Center the cine duration is calculated by assessing the patient’s breathing with the
external surrogate and adding one second to the average breathing period. The
extra second ensures the data acquisition sufficiency condition is met. The data
sufficiency condition requires the acquisition of data at each anatomic location to
be one breathing cycle plus the time needed to acquire one image, which is equal
to a gantry rotation. The gantry rotation used in this study is 500 ms, and an extra
500 ms is added to the cine duration to further ensure the data sufficiency
condition is met if the patient breathes more rapidly during image acquisition. The
cine time between images represents how often in time an image segment is
reconstructed. Cine 4D CT reconstructs images in real-time while helical
reconstructs the images after acquisition.
To calculate the number of image segments per couch position along the
cranial-caudal direction, the amount of time needed for data acquisition required
to form the initial image segment is subtracted from the cine duration, the result is
then divided by the cine time and 1 is added (Eqn. 1.2). For example, if the initial
image segment time is 500 ms per revolution, with a 250 ms cine time and 6s cine
duration, the total image segments per couch position will be 23, with the first
segment’s acquired data complete 500 ms after initial beam-on and the second
segment’s acquired data 750 ms after initial beam-on.

   


!" #" $ "  !%" 1 '
(1
!" "
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(1.2)
The initial projection time depends on whether the reconstruction is a full
reconstruction that requires 360 degrees of data for image segment reconstruction
or a segmental reconstruction of two thirds of 360 degrees (240 degrees) of data
required for each image segment reconstruction. The segmental reconstruction
increases temporal resolution at the expense of higher noise and image artifacts;
therefore the full reconstruction is standard at MD Anderson.
Because the cine image segments are acquired discretely and
independently of the external surrogate, the images cannot be reconstructed at
defined phases. Instead their occurrence in time is matched to the closest phase
definition in a nearest-neighbor technique termed phase sorting. Phase sorting is
the clinical standard post-processing method, which uses time both to define
phases based on placement within a user-defined breathing period and to select
the ‘nearest neighbor.’ Amplitude sorting is another common technique, but is not
commercially available; the T50%, or sixth phase definition is pushed to
exhalation and remaining phases are linearly defined based on amplitude to
inhalation. This process leads to artifacts that exhibit discontinuous banding that
typically appear medially across the anatomy (e.g,. Figure 1.1). All 4D CT scans
used in this research were acquired with a full reconstruction, with a detector
configuration of 8 x 2.5 mm slices, with a cine time between images ranging
between 350 ms and 450 ms.

4D CT ARTIFACTS
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I. Artifact Definition
Ideally the spatial distribution of pixel intensities of a physical object being
imaged exactly match the spatial distribution of pixel intensities of the image; an
artifact reflects a disruption in the correspondence between these intensities.(24, 25)
An artifact represents the true physical anatomy inaccurately in the image and may
manifest in a variety of ways depending on the cause; the artifacts we focus on in
this research are those arising from the cine 4D CT acquisition and processing
methods.

II. 4D CT Artifact Classifications
i) Helical vs. Cine Artifacts
As discussed in Chapter 1 section II, helical and cine 4D CT artifacts
differ based on the acquisition and processing used. Cine 4D CT artifacts exhibit a
banding discontinuity that typically appears medially across the entire sagittal or
coronal view (Figure 1.1), whereas helical 4D CT artifacts tend to exhibit more
smooth and localized (Figure 1.2) artifacts on the sagittal or coronal views.
Helical 4D CT artifacts may also exhibit banding discontinuities across an image
slice in the presence of large irregularities.
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Figure 1.1. Cine 4D CT Artifact Example. Green arrows point to a couch
position containing a cine artifact.

Figure 1.2. Helical 4D CT Artifact Example. Red arrows point to areas
containing artifacts.
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ii) Yamamoto Classification
A study by Yamamoto et al.(26) divided artifacts seen in 4D CT images
into four categories: blurring, duplicate, overlapping, and incomplete (Figure 1.3).
Blurring, or a partial projection artifact, occurs when organ motion is faster than
the speed of the image acquisition; this does not derive from the 4D process but
rather from patient-specific motion and scanner speed limitations.(27) The other
three classifications of artifacts derive from the 4D method and are common, with
reportedly roughly equal probability of occurrence and no significant difference in
artifact magnitude for each type.

Figure 1.3. Yamamoto Artifact Classification. Overlap (top left), duplicate (top
right), incomplete (bottom left), and blurring (bottom right).
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iii) Cardiac Artifacts
Cardiac artifacts appear in 4D CT scans as well and derive from the heart
beating asynchronously with breathing motion (Figure 1.4). Because cardiac
artifacts are not correctable with breathing, they will not be considered in this
study.

Figure 1.4. Cardiac Artifact Example. Red arrows point to the cardiac artifact.

4D CT ARTIFACT QUANTIFICATION
After a patient with thoracic cancer receives a 4D CT at MD Anderson, a decision
is made whether or not to acquire a second 4D CT scan based on the extent of artifact
presence in the first 4D CT. The second 4D CT is then evaluated, and if neither scan is
acceptable for treatment planning, then the free-breathing helical scan acquired over
multiple breathing states is used as an anatomic reference. The evaluation involves
manually assessing the overall acceptability of artifacts; this method is subjective,
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inconsistent, and requires the physician, physicist, or physics assistant to manually
evaluate the scan, which requires time and attendance. Currently some form of manual
observation is the standard of artifact evaluation in the clinic and in research studies,
however a reliable and efficient evaluation method is warranted.

I. Manual Assessment
Manual assessment by expert observers remains the standard method of
artifact evaluation but lacks guidelines, which makes artifact quantification
difficult. Some investigators display sample images with a general statement of 4D
CT scan quality in a relative fashion,(1, 28-40) and others define more explicitly a
method of manual evaluation by independent experts.(26,

41-44)

Manual artifact

assessment is also subjective, with potentially high inter-observer variation, and
lengthy analysis times.(45) Methods of manual assessment vary between institutions,
making comparisons of evaluated datasets between groups difficult. A robust,
reproducible, automated evaluation method that multiple centers can implement
would be ideal, although distinguishing true anatomic changes from false changes
resulting from 4D CT presents a challenge. The issues surrounding standard manual
assessment also make validation of the accuracy of quantitative methods difficult.

II. Quantitative Assessment
A limited number of studies focus on a metric of artifact evaluation; most
studies explore routes of artifact reduction with a simple method of quantifying the
reduction. Given the lack of artifact quantification methods, many studies have used
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images derived from phantoms and software simulations, in which the exact
anatomic volume and shape are known.(30, 35-37, 46-48)
Persson et al.(49, 50) evaluated artifacts in terms of gross tumor volume (GTV)
deviations from a reference target volume. This method is simple and the GTV is
delineated routinely on 4D CT scans used in treatment planning, however it does
not reflect spatial deviations or normal anatomic variations and may severely
underestimate the frequency of artifacts that are present. Other simple quantitative
artifact evaluations have included deviations in target centroid position or
contours(39,

51, 52)

(similar to the Persson study), the mean square gray value

difference between couch positions,(1) tidal volume variations from reference
images,(38) and external surrogate parameters.(53) These evaluation methods do not
account for normal anatomic variation and have not been validated against the
standard manual assessment. There are also studies that include only a general
statement that the quantitative results match observer results.(1, 39, 54)
Han et al.(55) used a normalized cross-correlation coefficient (NCC) to
evaluate artifacts in five helical 4D CT scans. A ‘bridge stack’ was identified as a
multi-slice set of images that overlapped locations with two adjacent multi-slice
image sets from the same phase, but occurred at a different phase than the two
adjacent images. No single threshold was found for NCC values in artifact
identification, so each patient had a range of sensitivity and specificity values,
making it difficult to determine the efficacy of this evaluation method. The standard
against which the NCC values were compared was not derived from manual
assessment but instead from the respiratory trace acquired by an external motion
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surrogate. The external surrogate does not correlate exactly with internal motion or
artifacts and therefore should not be substituted for actual image evaluation. This
method also is applicable only to helical 4D CT, and may be degraded if artifacts
are present in the reference bridge stack.
Cui et al.(56) devised a correlation metric (CM) for the assessment of cine
artifacts that attempts to account for normal anatomic variations. This metric
correlates the image slices across two neighboring couch positions and subtracts the
average of correlations between adjacent image slices within the neighboring couch
positions. This is a straightforward, efficient metric that could distinguish normal
anatomic variation from artifact and is very promising. However, this metric’s
validation was limited to relative metric values between 10 4D CT scans with two
observers.
Because an accurate method of artifact evaluation has not been established
yet remains critical for reduction studies, we rigorously validated the accuracy of
the Cui metric(56) which we believe to be the most promising metric.
In this work, a consensus group evaluated artifacts in 10 4D CT scans to form
a standard dataset. This dataset was then used to assess the performance of the
correlation metric in artifact identification(56) through receiver operating
characteristic (ROC) analysis.

4D CT ARTIFACT REDUCTION
Several efforts to reduce 4D CT artifacts have been undertaken but currently none
has been proven to significantly reduce artifacts. These efforts are generally in three main
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categories: alternative binning techniques, registration techniques, and alternative
acquisition techniques. Both alternative binning and registration reduction methods
typically use retrospectively acquired data, allowing their application to a large number
of samples. An alternative acquisition technique must be approved by human subjects
institutional review boards for patient testing; image simulations or anthropomorphic
phantoms(57) may be used, but do not truly reflect the results obtained from patients.

I. Alternative Binning Methods
i) Amplitude Binning
4D CT post-processing techniques sort images by breathing phase to
derive an estimate of the full anatomic deformation present during radiation
therapy. Whether the images are reconstructed at phase definitions or sorted based
on their nearest neighbor phase definition, breathing phases need to be defined
accurately to minimize delineation errors.(58) Clinically breathing phases are
‘phase binned,’ which bases the phase definition on time relative to a breathing
period; the peak inhalation points that determine the breathing period are defined
by a user. Many studies have tested alternative phase definitions with the goal of
increasing image accuracy while decreasing artifact presence. The most common
alternative phase definition is amplitude binning, which typically relies on
abdominal height or amplitude on the respiratory trace instead of time.
Rietzel and Chen(34) created software to define phases based on the
percentage of displacement between user-defined peak inhalation and peak
exhalation for cine 4D CT cases. They found that manual placement of peak
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inhalation and peak exhalation led to improved images compared with the
commercial system’s automatically selected peaks, and that amplitude-sorted
component phase image sets contained fewer artifacts. For proof of artifact
reduction, a sample set of coronal images between methods was presented with a
general statement that improvement had been observed. The same evaluation
found helical amplitude binning to produce superior image quality over phase
binning in a study reported by Fitzpatrick et al.(33) Lu et al.(38) not only found an
overall image quality improvement with cine amplitude binning, but validated the
greater accuracy of amplitude binning over phase binning through spirometry
measurements. Wink et al.(53) found artifact improvement with amplitude binning
on helical 4D CT, but only external surrogate-derived parameters were used to
estimate phantom image quality. Amplitude binning accuracy has also been
evaluated by measuring the consistency of a phantom sphere, with sample patient
images exhibiting artifact reduction from phase binning.(30)
One study(41) compared phase binning to amplitude binning locally (as in
previous studies) and globally, with a single peak inhalation and peak exhalation
definition based on percentiles. An expert evaluated artifact severity in patient
cases and concluded that global amplitude binning resulted in the poorest image
quality and that image quality was comparable between phase binning and local
amplitude binning. This study limited manual assessment to one observer who
scored 4 anatomic regions; thus, this evaluation was highly subjective and could
underestimate artifact frequency, but it does offer an interpretable estimate of
image quality. Another comparison study of binning methods used three experts
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to evaluate coronal-view image quality between percentile-based amplitude
binning and the commercially available phase binning.(44) The experts evaluated
only image areas corresponding to breathing irregularities in the respiratory trace;
the methods used to identify breathing irregularities were not stated. This
limitation of image regions underestimates the frequency of artifacts while relying
on the assumption that externally derived respiratory trace irregularities are both
directly correlated with artifact occurrence and are the only cause of artifact
occurrence.
Langner et al.(39, 46, 47) evaluated individual phase and amplitude binning
methods and also evaluated combinations of those and velocity-based binning
methods through 4D CT acquisition simulations. The authors incorporated a
method to account for breathing irregularities and only simulated images when
the respiratory signal fell within a chosen tolerance level relative to a reference
signal that was derived from a least-squares fit of Fourier analysis from at least 10
patient breathing cycles. Actively avoiding the acquisition of data during
breathing irregularities led to improved images over processing that lacked this
avoidance, and a combination of amplitude and velocity binning yielded the best
image quality among the binning techniques. Pan et al.(32) also used an alternative
processing method that accounted for breathing irregularities retrospectively.
Images associated with visually identified irregularities were flagged and were not
made available for final phase binning. That report included sample images of
artifact reduction achieved with this method.
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ii) Correlation-Based Processing
The binning methods discussed use a respiratory trace combined with
image occurrence information to yield a 4D CT with component phase image sets;
no image data are incorporated into the binning process. A few studies have taken
a more direct approach to artifact reduction by integrating a correlation-based
evaluation of artifacts in potential image combinations before the final image sets
are selected.
In one such study, Johnston et al.(59) sorted 10 cine 4D CT scans with
amplitude and phase binning alone, as well as each binning method extended to
include not only the nearest neighbor but also all neighbors within a tolerance
around the nearest neighbor. This approach yields multiple potential phase image
sets with the final phase sets dictated by the highest correlation coefficients; the
higher the coefficient for a given image set, the less probable it is that that image
set contains artifacts. Two experts visually evaluated a sample of traditionally
binned images simultaneously against the correlation-sorted images and
concluded that the addition of the correlation parameter reduced artifacts.
Use of the normalized cross correlation coefficient (NCC) to ‘daisy chain’
image segments has also been studied. Carnes et al.(28) acquired cine image
segments with an overlapping slice to provide an anatomic link for selecting the
highest NCC value among available images. These images were then ‘daisy
chained’ by matching image segments one at a time beginning inferiorly, as
opposed to the Johnston study, which used an algorithm to optimize the highest
correlation path for the entire 3D CT. A root-mean-square difference of NCC
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values was the quantitative artifact evaluation metric, and overall improvement in
image quality was manually noted. A similar study evaluated image quality
according to registration displacements and also found improvement in image
quality.(60)

II. Registration Methods
Registration and alternative computational methods have also been
intensively studied as tools for reducing and often eliminating 4D CT artifacts in
retrospectively gathered data. Hertanto et al.(37) amplitude-sorted cine 4D CT images
and then registered a gap-free reference phase image set to each component phase
set, extracted a motion model using principle component analysis, and applied the
model to synthesize gap-free amplitude-sorted images. Another study followed this
method but synthesized all phase-sorted component image sets by using a demons
algorithm.(35)
Alternatives to a 1D external breathing surrogate such as internal motion
models(9) and 3D skin models(61) have been developed with registration to improve
respiratory trace accuracy. Registration models have been applied to generate more
accurate 4D CT phase sets by interpolating images at defined phases, yielding
reduced artifacts in comparison to nearest neighbor phase sets.(1, 40) Gianoli et al.(36)
used a K-means clustering technique to sort cine 4D CT images with a 3D surface
tracker and compared results to phase and amplitude-sorted image sets of a
phantom and two patients. They concluded that the clustering technique reduced
artifacts from both phase- and amplitude-sorted scans and improved proper phase
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identification. Another study used NCC values, registration, and a graph-searching
method to ‘stitch’ multi-slice images together to reduce artifacts.(42) Wolthaus et
al.(62) registered 4D CT scans and extracted a new 3D CT of the mean of
deformation positions to create an optimal primary planning dataset with reduced
artifacts.
Many of these registration studies reduce, if not eliminate, artifacts by
synthesizing images, but limited by the need to estimate lung CT numbers, which
vary with density changes in breathing deformation,(63, 64) limiting their usefulness
of these images in treatment planning and calculations. These methods also carry a
high computational cost and must have quality control in place to certify their
accuracy before synthesized images can be used for treatment planning.

III. Alternative Acquisition Methods
Experimental acquisition methods constitute only a small portion of 4D CT
artifact reduction studies because of the challenges associated with patient accrual
and data acquisition, working with pre-existing machine settings, or both.
Challenges associated with pre-existing machine settings has led to many reduction
studies that use CT scanners with an extended beam width capability; challenges
associated with patient acquisition may be addressed through a protocol approved
by an institutional review board or by using phantoms.
Coolens et al.(48) acquired 4D CT scans of a phantom by using a helical 320slice Toshiba CT scanner that covered 16 cm of superior-inferior extent and with a
more conventional 16-slice Philips CT scanner. Sinusoidal and irregular patient
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breathing patterns were applied and phantom volumes and centroids were assessed
relative to the manufacturer’s specifications. The extended extent acquisition
resulted in less error than the conventional helical scan and in a faster scan time.
McClelland et al.(65) performed a similar extended extent acquisition in combination
with registration to create an accurate model of the motion states. This method
acquired the entire extent in three to four image segments for five patients and
compared them with the model derived with visual assessment. These investigators
concluded that the model produced more accurate images, but because the extended
extent acquisition was not compared with a conventional acquisition, no statement
of improved quality could be made for the acquisition alone.
A series of studies using a larger cine superior-inferior extent concluded that
the longer extent reduced 4D CT artifacts. A 256-multidetector row CT was used in
each study that covered a 12.8 cm extent within one rotation. The first study(66)
compared two reconstruction algorithms and their effects as evaluated within
treatment plans. The second study(51) used this acquisition method for 14 patients
and evaluated image quality by contouring the GTV in each phase and evaluating
the contours on fusion images with the conventional treatment planning 4D CT;
GTV margin differences and linear motion extent were also evaluated between
scans. That approach was found to produce a significant improvement in image
quality, more accurate margins, and a shorter scanning time. A third study(52)
focused on evaluating pancreatic motion in six patients and found a significantly
reduced target margin and a more accurate determination of anatomic spatial
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distributions. Unfortunately these studies focused mostly on target deviations and
therefore underestimate the total artifact occurrence.
Low et al.(67) combined an experimental acquisition technique with
deformable registration to generate artifact-free 4D CT scans with more accurate
CT numbers. A patient with abdominal cancer was scanned on a 64-slice helical CT
25 times in alternating scanning directions. The scans were correlated with the
external breathing surrogate, and a motion model was derived through a registration
technique previously established by the same authors. The model was used to
deform the 25 image sets into user-defined breathing phases reported to have no
artifacts. Sample images of the patient scans acquired were displayed, but the
model’s accuracy in the generation of correct CT numbers or correct spatial
distributions of anatomy is unclear.
Keall et al.(31) explored the potential of artifact reduction through prospective
gating by halting image acquisition for a breathing irregularity. Phantom images
were acquired during a breathing irregularity, and then using beam gating during
the irregularity. Visual comparison showed improved quality of a sample coronal
image from the gated acquisition compared with the image acquired during the
irregularity.

HYPOTHESIS & SPECIFIC AIMS
HYPOTHESIS
The 4D CT anatomic misplacement error, quantified by using a correlation-based
metric, can be reduced by 30% using one of the following redundant imaging
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strategies: (1) Extended acquisition, (2) Manual real-time gating, or (3) Repeat
imaging of irregular segments.

Specific Aim 1: Validate an automated artifact detection algorithm. A consensus
group’s visual assessment of artifacts in 10 cine 4D CT scans was used as a high-quality
dataset to assess the accuracy of a correlation-based artifact metric.
Specific Aim 2: Compare 4D CT artifacts in three experimental image acquisition
methods. Patients received a standard clinical 4D CT scan followed by each of the three
experimental methods: (1) acquiring images over two breathing cycles per couch
position, (2) gating breathing irregularities out of the x-ray beam, and (3) re-scanning at
couch positions associated with breathing irregularities.
Specific Aim 3: Test the reproducibility of the experimental method that reduces the
artifact frequency, magnitude, or both to the greatest extent. A second cohort of
patients received a clinical standard 4D CT followed by the experimental method that
demonstrated the highest reduction of artifacts, as determined in Aim 2. The chosen
method is repeated twice for reproducibility evaluation.
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CHAPTER 2
VALIDATION OF THE ARTIFACT QUANTIFICATION METRIC

This chapter is based upon the publication,
Castillo SJ, Castillo R., Balter P, Pan T, Ibbott G, Hobbs B, Yuan Y, Guerrero T,
Assessment of a Quantitative Metric for 4D CT Artifact Evaluation by Observer
Consensus Journal of Applied Clinical Medical Physics, in press (May, 2014.)

INTRODUCTION
An artifact reduction cannot be accurately proven without a viable means of
artifact quantification. To carry out Specific Aim 1, a simple, automated cine artifact
metric was identified for a novel validation approach. Cui et al.(56) devised a correlation
metric (CM) for assessment of cine artifacts that attempts to account for normal
anatomical variations. This metric correlates the image slices across two neighboring
couch positions and subtracts the average of correlations between adjacent image slices
within the neighboring couch positions. This straightforward, efficient metric could
distinguish normal anatomic variation from artifact and is thus very promising. However,
validation of this metric was limited to relative metric values between 10 4D CT scans
with two observers, and could be improved by a receiver operating characteristic
(ROC)(68) analysis(69, 70) to assess the accuracy of the metric in identifying artifacts. The
current standard of artifact evaluation is manual visual assessment, which is associated
with high inter-observer variability, lack of quantitative power, and lengthy analysis
times. A consensus group of expert observers may reduce analysis times and interobserver variation, yielding a higher-quality standard-evaluation dataset.
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THE ARTIFACT QUANTIFICATION METRIC
For this Aim, a consensus group evaluated cine artifacts in 10 4D CT scans to
form a standard dataset. This dataset was then used to assess the performance of the
correlation metric (CM) in artifact identification(56) through ROC analysis.

I. The Normalized Cross Correlation Coefficient
The metric proposed by Cui et al.(56) is based on a normalized crosscorrelation (NCC) coefficient between two axial images (Eqn. 2.1). This coefficient
is commonly used in template matching to determine the position of a given pattern
in an image.(71) The position of a template  within an image ) *, ,' is given by
-, .', where / is the mean of the template pixel intensities and )0-,. is the mean of
) *, ,' pixel intensities in the region under the template. The maximum NCC value
gives the position match.
122 

∑*,, 4) *, ,' $ )0-,. 54 * $ -, , $ .' $ /5'
8

∑*,,6) *, ,' $ )0-,. 7 ∑*,,4 * $ -, , $ .' $ /58 '9.;
(2.1)

II. The Pearson Correlation Coefficient
The Pearson correlation coefficient C is typically used in correlation studies to
assess a linear relationship between two variables or images.(43) The 2D Pearson
correlation coefficient was used in this study (Eqn. 2.2) for efficiency in correlating
an image A with a second image B, where </ is the mean of image A pixel
intensities, =0 is the mean of image B pixel intensities, and (m,n) are indices of pixel
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rows and columns respectively. The Pearson correlation coefficient C is equal to the
maximum NCC coefficient when the two images are properly aligned. We chose to
use the Pearson correlation coefficient rather than the NCC coefficient because the
Pearson correlation coefficient requires less computation time and is more
intuitively understood.
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III. The Final Artifact Metric
All calculations were performed using MATLAB (The MathWorks, Inc.,
Natick, MA) with the corr2 function (Eqn. 2) for the correlations. The correlation
metric (CM) devised by Cui et al.(56) (Eqn. 2.3) was calculated between each couch
position N per breathing phase per 4D CT scan. A couch position is a reference to a
beam-width size superior-inferior location across the scan extent; each couch
position contains a sorted image segment with a detector configuration of 8 x 2.5
mm thick axial images. The Pearson correlation coefficient C was calculated
F
between image seven and image eight of couch position N (CD,E
), then between
FIG
image one and image two of the inferior couch position N+1 (CG,H
); the resulting

two coefficients were averaged to account for normal anatomical variation. The
coefficient between image eight of couch position N and image one of couch
F,FIG
position N+1 (CE,G
) was subtracted from this average, yielding the final metric

CM. Lower CM values indicate a better image match, and a lower artifact severity.
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Each 4D CT scan had a corresponding matrix of ((NT-1) J 10) CM values where NT
is the total number of couch positions per each of 10 phases.
F,FIG
FIG
F
CK  0.5NCD,E
( CG,H
O $ CE,G

(2.3)
One metric per each couch position two through NT-1 was needed for
comparison with observer results, so each couch position’s bordering CM values
were averaged to mimic how an observer would assess a couch position for artifact
presence. A final normalized correlation metric (NCM) was calculated by dividing
each CM value by the average of CM values within that phase. This normalization
allowed retention of the relative values for comparison between 4D CT scans and
between phases while yielding a common reference point for 4D CT scans.

THE SAMPLE EVALUATED
I. The Sample Data
We identified 10 patients scheduled to undergo thoracic radiation therapy at MD
Anderson. Our study sample consisted of the clinical cine 4D CT scans used to
generate the primary dataset for each identified patient’s radiation treatment plan.
All 4D CT images were acquired using a GE Discovery ST PET/CT scanner (GE
Medical Systems, Waukesha, WI) with the 8-slice LightSpeed CT component and
were retrospectively reviewed. All image segments contained eight axial images,
each with an x and y voxel size of 0.97 mm, and a z voxel size of 2.5 mm. Phases
were binned evenly in time between user-defined maximum inhalation peaks for all
cases. Maximum inhalation is represented by T0% with each subsequent breathing
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phase per cycle defined in 10% increments of the breathing period for that cycle,
i.e. T0%, T10%, T20%, etc. All 4D CT scans were phase-sorted with this binning
technique by using the GE Advantage Workstation software.

II. The Sample Size Calculation
A sample size calculation estimated the minimum number of 4D CT scans
necessary for metric evaluation. Two cohorts were needed, one to determine a
metric threshold for artifact identification and a second to evaluate the determined
artifact threshold. We calculated an exact test for single proportion (Eqn. 2.4) to
determine the sample size with the software nQuery Advisor (Statistical Solutions,
Boston, MA). Given x successes out of n trials, x=0,1,…,n, the p-value for an exact,
two-sided binomial test under null success rate π0 is computed by summing the
probability of observing values of the sample space that are as extreme or more so
than x.
∑VRWU

P!
R! PSR'!

P!

TUR 1 $ TU 'PSR + ∑PRWPSVSG R! PSR'! TUR 1 $ TU 'PSR
(2.4)

A test of significance at an alpha level of 0.1 was used with type 1 error and a
power of 0.81. A two-sided null hypothesis of 0.5 with an alternative of 0.75 was
chosen, indicating that the metric could not definitively identify an artifact or that it
could identify at least three artifacts of every four artifacts present. This yielded 26
artifacts needed per cohort. If at least one artifact exists per breathing phase per 4D
CT scan, then a single 4D CT scan would contain at least 10 artifacts. Therefore,
five 4D CT scans per cohort were evaluated, yielding approximately double the
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number of artifacts needed. Each 4D CT scan was briefly visually assessed to
ensure that this minimum artifact requirement was met.

OBSERVER ARTIFACT ASSESSMENT
I. Consensus Group
Thorough visual assessment is time-consuming and associated with high interobserver variance,(45) but it remains the standard artifact evaluation method. To
reduce both the time required and the inter-observer variance, we organized a
committee of observers to view images simultaneously and reach a consensus on
artifact location and magnitude. We termed this committee the consensus group.
The consensus group consisted of a physician specializing in thoracic oncology, a
physics assistant working with cine 4D CT, two physicists in the thoracic service,
and a dosimetrist who works with thoracic treatment plans. An independent
member, a graduate student studying 4D CT, coordinated each assessment and
distributed materials necessary for evaluation but did not participate in the actual
assessment.

II. Consensus Group Instructions
Before the first consensus group meeting, instructions for artifact evaluation
were given to all of the consensus group members. The same instructions were
provided at each consensus group meeting. The instructions included definitions
and examples of cine 4D CT artifacts with our magnitude scoring system, as well as
an example of a cardiac artifact that results from the heart beating asynchronously
from the breathing motion of the lung, which could be mistaken for a 4D CT
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artifact. These instructions served as a baseline reference to calibrate each
observer’s visual scale.

III. Artifact Evaluation Method
If a couch position within a breathing phase was identified as containing an
artifact, it was assumed that the identified artifact existed at all image slices at that
couch position within that phase. All couch positions covering lung anatomy were
assessed; couch positions below the displayed inferior lung were considered in the
assessment if there appeared to be an artifact at that location that was interfering
with display of what should have been the most inferior lung anatomy. Each
identified artifact was assigned a magnitude score between 1 and 5, with 1
indicating an artifact with a minor degree of interference with true anatomy and 5
indicating a large degree of interference with true anatomy; Figure 2.4 gives an
example of artifact scores assigned.
Coronal views were assessed in all 10 phases for each patient. A helical deepinspiration breath-hold scan acquired within the same examination as the 4D CT
scan was displayed next to the 4D CT scan during assessment to serve as an
anatomic reference, as such scans are free of the cine 4D CT artifacts being
evaluated. Artifacts were assessed by using custom MATLAB software that
allowed simultaneous coronal display of a component breathing phase of the 4D CT
and the coronal display of the breath-hold. This software also allowed the ability to
scroll through the images, change the window and level, zoom in or out, display the
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couch position locations, change the breathing phase, and save an identified
artifact’s corresponding couch position and score (Figure 2.1).
Before the 4D CT evaluation, a lung window of level -450 HU and window
1100 HU was set for both the breath-hold scan and the 4D CT scan. Each was
zoomed so that the entire lung with an extra couple of surrounding couch positions
could be viewed. The couch positions of the 4D CT scan were displayed after the
zoom so that observers could identify the correct couch positions. Two sets of
numbered cards were distributed to each observer, and the observers used these
cards to identify couch positions and scores for artifacts independent of the other
observers’ choices.

Figure 2.1. Artifact Evaluation Software. Left, T0% of a 4D CT scan with a
highlighted identified artifact at couch position 13, indicating a saved artifact
location. Right, corresponding deep-inspiration breath-hold scan used as an
anatomic reference for artifact identification in the 4D CT (left).
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The breath-hold scan was scrolled through before each 4D CT evaluation for
anatomic reference, and then the entire lung in the selected 4D CT breathing phase
was scrolled through, allowing time for observers to choose their numbered cards
for artifact location and score. Then for each couch position within the lung, the
consensus group was asked if the stated couch position contained an artifact. Each
observer shared the numbered cards he or she had chosen. Results were saved if all
consensus members agreed on an artifact location and score; if different answers
were chosen, the observers made a case for their reasoning and the images were
reviewed until the group achieved a consensus. Only rarely was no consensus
reached; in those cases, the majority ruled.

IV. Analysis of Consensus-Chosen Artifacts
A logistic mixed effects model was used to evaluate the relationship between
artifact incidence and breathing phase from consensus results from all 10 patient
cases by using the lme4 package in R.2.14.0

(http://www.r-project.org/). This

utilized mixed logistic model facilitates joint estimation of the log-odds of artifact
incidence across all phases while accounting for the inherent correlation among
observations derived from the same patient scan to estimate and characterize the
extent of variability associated with a breathing phase. The likelihood ratio test for
association is reported; this test is used to weigh the observed evidence of
homogeneity, i.e. the identical log-odds for all phases.
In addition, phase effects were evaluated for significance using two-sided
Wald tests. Wald tests are used to weigh the observed evidence of phase specific
log-odds adjustments from component phase T0% in the presence of the estimated
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within and between subject sources of variability. Post-hoc application of the
sequentially rejective Bonferroni method was used to adjust p-values for multiple
comparisons of the adjustments of log-odds of artifact incidence from component
phase T0% across phases T10% through T90%.(72) The multiple phase comparisons
inflate the nominal false positive rate, and thus the p-values need to be adjusted to
maintain the type I error rate at 5%.

ARTIFACT THRESHOLD DERIVATION
I. ROC Curve Generation
An ROC method was used to determine an artifact threshold with cohort 1; this
artifact threshold was then applied to cohort 2 to evaluate the resulting sensitivity
and specificity. The artifact threshold is an NCM value. A 4D CT contains NCM
values for each component breathing phase at each couch position except for the
first and last as given in the matrix ((NT-2) J 10). The NCM values above or equal
to the applied artifact threshold value indicate an artifact at an anatomic location (N)
and breathing phase. MATLAB software was developed to format observer results
and produce ROC curves.
To generate ROC curves, a binary decision threshold is moved across the data,
above which an artifact is identified, while below which an artifact is not identified;
each decision threshold yields a sensitivity and false-positive fraction point on the
curve.(20) The decision threshold was incremented by 1% between the minimum
NCM value and the maximum NCM value contained within each cohort 1 patient
((NT-2) J 10) matrix. As the decision threshold was incremented, NCM values
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below the decision threshold were set to zero, indicating no artifact presence. The
consensus results served as the “ground truth” to determine the true-positive
fraction, true-negative fraction, false-positive fraction, and false-negative fraction.

II. ROC Curve Parameters
Parameters were calculated from the ROC curves to assess the accuracy of the
NCM and find the resultant artifact threshold. For each patient in cohort 1, the area
under the curve (AUC) was calculated to determine the NCM accuracy, and the
Youden index was calculated to extract a threshold. The Youden index J is the
maximum vertical distance between the ROC curve and the diagonal “chance line,”
which can also be related back to a decision threshold point directly (Eqn. 2.5).
X  max ""\"] #!' ( ^!""!"] #!' $ 1'
(2.5)
The Youden index represents the optimal cut-point in ROC curve analysis and
is used as another measure of accuracy. Youden index values vary between 0 and 1,
with 1 indicating a relatively large NCM evaluation accuracy.(73) The artifact
threshold was derived from the Youden index to provide the optimal artifact
threshold corresponding to maximum accuracy in each ROC curve. The point in the
curve at which the Youden index was found yielded the corresponding NCM
threshold.

III. Artifact Threshold
The artifact threshold corresponding to the minimum Youden index found in
cohort 1 was taken as the final artifact threshold. One outlier index was found, and
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thus an average of thresholds was deemed inappropriate, and the minimum was
taken to ensure that artifacts would not be missed.

ARTIFACT THRESHOLD EVALUATION
The determined artifact threshold was applied to each ((NT-2) J 10) matrix of NCM
values in cohort 2. All cohort 1 ROC curves and parameters, and cohort 2 sensitivity and
specificity values were calculated using consensus group results as the ground truth.

METRIC VS CONSENSUS-CHOSEN ARTIFACT MAGNITUDES
To evaluate whether the relative NCM values accurately reflected the degree of
artifact severity, or artifact magnitude, the artifact score for each consensus groupidentified artifact among all 10 cases was compared to the NCM value corresponding to
the couch position and breathing phase of that artifact score. A Pearson correlation
coefficient and a p-value were calculated for each patient.

BREATHING IRREGULARITY
I. Breathing Irregularity Identification
Breathing irregularity identification for this research was performed by using a
simple method based on finding outliers across the scan extent. Because each couch
position contains at least one breathing cycle with 10 phases, multiple breathing
phases per component phase exist across the scan extent. The corresponding
amplitudes of the multiple breathing phases were averaged per component phase to
yield a baseline for regular breathing identification. A phase was considered
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irregular when the amplitude existed outside a tolerance range set by the mean
amplitude ±1 SD of said phase (Figure 2.2).

Figure. 2.2. Breathing Irregularity Identification. Patient respiration (blue),
beam-on signal (green lines), T0% phases (green circles). T0% mean (middle
horizontal dark blue line), T0% SD (outer pink horizontal lines), T0% irregular
phases (red stars).

II. Breathing Irregularity vs Consensus-Chosen Artifacts
Three questions concerning breathing irregularities and artifacts were
addressed: (1) if artifact presence is indicative of breathing irregularity presence, (2)
if breathing irregularity presence is indicative of artifact presence, and (3) how
artifact magnitude relates to breathing irregularities.
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To answer the first question, whether or not an observed artifact corresponds to
a breathing irregularity, each chosen artifact location per patient was identified and
flagged if a breathing irregularity occurred during image acquisition at that location.
The percentage of the total number of irregular phases occurring at a consensuschosen artifact position per all consensus-chosen artifact positions was examined
and averaged across the 10 consensus patient results.
The second question was addressed similarly to the first; the total number of
breathing irregularities that occurred during image acquisition of the lungs was
flagged, as well as the artifacts identified corresponding to those irregularity
locations. The percentage of the total number of consensus-chosen artifacts that
occurred at breathing phase locations identified as irregular per total number of
irregular breathing phase locations was calculated. The distribution of mean artifact
and irregularity quantities per phase per patient was also evaluated.
Finally, to compare artifact magnitudes, or scores, against irregularity presence
we tallied the number of artifacts per score across phases per patient associated with
a breathing irregularity and unassociated with a breathing irregularity. The 10
values per score were averaged and correlated with score.

RESULTS
I. Artifact Metric
Evaluated cases were labeled first by the cohort (C1 or C2) followed by a
number indicating the order of evaluation within that cohort. An example of NCM
values over all couch positions for two component phases for the first patient of
cohort 2, C2_1, is shown in Figure 2.3; coronal image slices from the same two
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component phases of the C2_1 case are shown in Figure 2.4 for comparison to
Figure 2.3 and as an example of consensus-chosen scores.

Figure 2.3. Normalized Correlation Metric vs Couch Positions, Patient C2_1.
Breathing phases T10% and T90% are displayed for comparison with coronal views
of T10% and T90% in Figure 2.4.
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Figure 2.4. Example Coronal Slices of Patient C2_1. Examples are T10% (left)
and T90% (right) (NCM values shown in Figure. 2.3), with couch positions
indicated on the left side of each coronal view and consensus group identified
scores per couch position shown on the right side of each coronal view. The artifact
in T10% at couch position 11 was scored as being more severe based on the higher
interference of the artifact with anatomy.

II. The Consensus-Chosen Artifacts
The consensus group scored all 10 phases of a 4D CT scan in less than 40
minutes, on average within 30 minutes. The mean percentage of couch positions
covering lung anatomy that contained consensus-chosen artifacts for both cohorts
was 68.7%. The first patient scored by the consensus group had the lowest
percentage of lung couch positions containing artifacts at 32.4%; all other patients
had artifacts in at least 59% of lung couch positions with a maximum percentage of
87.3%.
Artifact incidence was significantly associated with breathing phase by using
logistic mixed effects analysis (p<0.002 likelihood ratio test). The estimated
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probability of observing an artifact during the T60% phase was significantly lower
than T10% (odds ratio=0.44, p<0.003), T70% (odds ratio=0.41, p<0.0015), T80%
(odds ratio=0.33, p<0.0002), and T90% (odds ratio=0.36, p<0.0004) phases after
adjusting for multiplicity. Figure 2.5 demonstrates the model-estimated probability
of an artifact at each phase with 95% confidence intervals.

Figure 2.5. Estimated Probability of Artifacts as a Function of Phase.
Associated 95% confidence intervals indicated by grey bars. The risk of an artifact
was lower for exhalation phase images. The p-value derives from the likelihood
ratio test of the global null hypothesis of the absence of an association with phase.
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III. ROC Analysis
Figure 2.6 demonstrates a sample ROC curve generated for case C1_5, with the
associated parameters; Table 2.1 displays the ROC curve parameters for all five
patients in cohort 1. The artifact threshold found using this method was 73%. The
average (AVG) cohort 2 sensitivity resulting from the applied artifact threshold of
73% was 0.703, and the average specificity of cohort 2 was 0.476, each with a
standard deviation of 0.11. All cohort 2 values are given in Table 2.2.

Figure 2.6. Example ROC Curve from C1_5. Parameters displayed are area
under the curve (AUC), Youden index, and corresponding NCM threshold.
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Parameter

C1_1

C1_2

C1_3

C1_4

C1_5

AUC (Area Under Curve
ve)
Youden Index
NCM threshold

0.756
0.446
125%

0.525
0.103
73%

0.769
0.507
93%

0.709
0.461
93%

0.801
0.545
81%

Table 2.1. Cohort 1 ROC Parameters

Table 2.2. Cohort 2 Sensitivity and Specificity Values
1

AVG: average, 2 SD: standard deviation.

IV. Metric vs Consensus--Chosen Artifact Magnitudes
The mean of cohort 1 Pearson correlation coefficients was 0.80, with all but the
first case yielding a coefficient greater than 0.91; the composite correlation
coefficient was 0.54. The mean of cohort 2 Pearson correlati
correlation
on coefficients was
wa
0.61, with three of the five cases yielding coefficients greater than 0.99; the
composite correlation coefficient was 0.58. The composite pp-values
values for both cohorts
were less than 0.001, indicating a nonzero correlation between the NCM and
consensus scores.
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V. Breathing Irregularities vs. Consensus-Chosen Artifacts
The mean percentage breathing irregularities occurring at the same couch
location and phase as each consensus-chosen artifacts across all patients was 37.8%
(range: 23.7%-53.5%); values per phase are shown in Figure 2.7. The mean
percentage of consensus-chosen artifacts occurring at the same couch location and
phase as each breathing irregularity across all patients was 68.4% (range: 49.7%81.6%); values per phase are shown in Figure 2.8. The total numbers of consensuschosen artifact scores (range 1-5), with and without corresponding breathing
irregularities, are shown in Figure 2.9.

Figure 2.7. Percentage Breathing Irregularities at Artifact Locations. Boxplot
of percentage of breathing irregularities that occur at the same location as
consensus-chosen artifacts.
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Figure 2.8. Percentage Artifacts at Irregular Breath Locations. Boxplot of
percentage of consensus-chosen artifacts that occur at the same location as
breathing irregularities.
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Figure 2.9. Artifact Scores and Breathing Irregularities. Total number of
consensus-chosen artifact scores with and without a corresponding breathing
irregularity.

DISCUSSION
We found that the average sensitivity and artifact score correlation achieved for the
NCM assessment against the consensus group assessment indicated that the NCM
method performed moderately well for evaluation of cine 4D CT artifacts. The sensitivity
was high but the specificity was only moderate, suggesting that the artifact threshold
found using cohort 1 overestimated the true number of artifact locations. This was
expected, because we chose the artifact threshold corresponding to the minimum Youden
index, the cohort 1 outlier, to favor not missing an artifact at the expense of falsely
identifying a position as containing an artifact. However, even with this trade-off, the
sensitivity was not as high as expected. This may be due to the inexperience of the
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consensus group members present with the scoring system for the first few cases. If the
consensus group members had participated in a practice session an outlier might have
been avoided, and the artifact threshold would have been derived over an average of the
sample rather than from the outlier value. Had a larger number of patients in cohort 1
been evaluated, a decreased outlier detriment would have allowed an average-derived
artifact threshold.
The artifact score correlations between the NCM values and consensus results were
good on an individual basis, but a few cases with poor coefficients reduced the composite
correlation coefficient. The first case had a poor coefficient (0.169) that, as noted above,
would have been improved if a practice session had been included to familiarize the
observers with the procedure and scoring system based on the given instructions. The
other two cases with poor coefficients (0.342 and 0.408) had no consensus magnitude
scores higher than 2, which left only two data points for the correlation. An increase in
number of patients in cohort 1 might also have provided more cases with scores over the
range 1-5 to offset these poor correlations.
This study would have benefited from a practice session to train observers before the
consensus evaluations and an increased cohort 1 sample size of patient 4D CT cases to
offset the effect of an outlier and provide more data points for artifact score correlation.
However, even with these weaknesses, the consensus group method of visual assessment
allowed an efficient and guided scoring that produced a high-quality research dataset for
metric validation, reduced inter-observer variation, and provided a more consistent
method of identifying artifact locations and magnitudes. The NCM also performed well
despite these issues and resulted in a reproducible automated quantitative evaluation
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within a time that could not be achieved by observer evaluations; the NCM is also simple
to implement as it is based on the Pearson correlation coefficient, and thus would
integrate well into the clinical workflow.
The results of the logistic mixed effects analysis demonstrated that artifacts were less
likely to be present near exhalation. This is intuitive, because exhalation is a more stable
breathing state; passive exhale ends at the functional residual capacity, the equilibrium
point between the chest wall expansion and lung contraction. In particular, a significant
reduction in artifact odds was noted at T60% when compared to T10%, T70%, T80%,
and T90%. These images were phase-sorted using 10 equally divided bins, and did not
explicitly define T50% to be maximum exhalation. As time from peak inhalation to peak
exhalation is typically longer than time from peak exhalation to peak inhalation,(74) T60%
may have more truly represented maximum exhalation than other phases such as
T50%,(75) providing an explanation for why only T60% contained a significant artifact
reduction.
The relationship between breathing irregularities and artifacts remains, but is not
exact. The presence of a breathing irregularity indicates the presence of an artifact in
roughly two-thirds of cases, whereas the presence of an artifact was associated with an
irregularity roughly a third of the time. An irregularity causing an artifact to occur has a
strong association, but irregularities may not always be the cause of an artifact. This is
intuitive because artifacts are not always caused by a breathing irregularity; an artifact
may also be caused by the lack of RPM correlation, phase mis-assignment errors, or from
the acquisition or post-processing technique. We expected that higher-magnitude artifacts
would be associated with a higher number of breathing irregularities, but this was only
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apparent for the score of 4. This may reflect the lack of data points for the higher scores,
particularly for score 5, or the lack of a more robust irregularity detection that would also
allow a magnitude to be scored.
Currently, visual assessment is the evaluation standard, but it lacks a clear set of
rules, which makes extraction of quantitative results difficult. Some reports of visual
assessments display sample images with a description of the overall artifact presence
whether on an individual basis or as a comparison between scans,(1, 28-32, 34, 36-40) whereas
others state a particular method of an independent expert evaluation.(26, 41-44) Our study
extracted a quantitative artifact evaluation from qualitative observations in a guided and
efficient method that reduced inter-observer variability. This yielded a high-quality
research dataset for 10 breathing phases of 10 patients in approximately five hours. This
consensus group method of evaluation could also be used for images from various
acquisition and processing methods and even for various types of artifacts, provided that
instructions on identification and characterization are provided, preferably with a practice
session before the first case analysis.
Similar evaluations have been done with images derived from phantoms and
software simulations, in which the exact anatomical volume and shape are known.(30, 35-37,
46-48)

Persson et al. evaluated artifacts in terms of GTV deviations in comparison with a

reference target volume.(49, 50) Other quantitative artifact evaluations include: deviations
in target centroid position or contours,(39, 51, 52) the mean square gray value difference
between couch positions,(1) tidal volume variations from reference images,(38) and
external surrogate parameters.(53) The quantitative metric evaluated in this study offers an
efficient, reliable method to evaluate cine artifact location and magnitude in the lung.
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CONCLUSION
We conclude that the correlation metric assessed has promise for use in the
evaluation of artifacts on cine 4D CT scans, when an efficient and reliable method is
needed for processing many sets of images, although additional cases would yield an
even more accurate artifact threshold for identification. We also conclude that the
consensus group method has the potential to be used as a research standard for evaluating
4D CT artifacts and as a standard to evaluate alternative quantitative artifact evaluation
methods, and we recommend that the consensus group have a practice session before
evaluation.
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CHAPTER 3
EXPERIMENTAL 4D CT ACQUISITION METHODS

INTRODUCTION
4D CT artifacts cause uncertainty in the true anatomic spatial distribution and could
lead to errors in treatment planning delineation and targeting; these artifacts have been
demonstrated to affect emerging applications such as lung function images derived from
CT.(26, 27, 49, 50, 76, 77) In addition to artifacts common in diagnostic CT, 4D CT images are
subject to artifacts caused by irregular breathing(1, 26, 27, 31, 32, 37, 49, 58); irregular breathing
is currently not corrected for in the clinical setting. Although breathing irregularities may
introduce appreciable artifacts into the 4D CT, the current clinical strategy is to use the
low-quality dataset for treatment planning or to re-acquire the 4D CT scan. If the reacquired 4D CT still demonstrates appreciable artifacts, free-breathing helical acquired
CT images are used to aid in treatment planning. The use of these images was standard
practice prior to the introduction of 4D CT methods, but it does not account for
respiratory motion.
Several research groups have reported methods to reduce 4D CT artifacts by
reducing the data that are acquired during breathing irregularities. Langner et al.(39, 46, 47)
compared sorting methods to reduce respiratory motion artifacts in a retrospective
simulation study. A model simulated CT images when a patient respiratory signal fell
within a tolerance limit of a reference respiratory trace, and only those images were used
in the sorting process. By simulating images only when the respiratory waveform was
within the tolerance limit of the reference signal, a higher quality 4D CT was produced
compared to retrospective phase sorting using all of the images.(39, 46, 47)
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Pan et al.(32) reduced cine 4D CT artifacts by identifying the data acquired during
irregular breathing and disabling the use of that identified data in phase sorting. Sample
coronal and sagittal views visually demonstrated improved image quality when these
irregular portions were excluded; however this was only applied to one region of the scan
extent.
Keall et al.(31) explored the potential for artifact reduction through prospective gating
by halting the image acquisition for a breathing irregularity. Coronal images of a
phantom were acquired both during a breathing irregularity and by using beam gating to
exclude the irregularity. The image acquired with gating was found by visual comparison
to be of better quality than the image that was not gated.
Despite these promising results, to the best of our knowledge, methods to
prospectively reduce 4D CT artifacts by altering the acquisition have not been attempted
in a clinical setting. In the present study we implemented three experimental 4D CT
acquisition methods that target breathing irregularities: (1) acquiring more images, (2)
gating the x-ray beam with breathing irregularities, and (3) re-acquiring images
associated with breathing irregularities in patients with thoracic cancer to determine the
potential for improving 4D CT image quality in a clinical setting in a relatively simple
manner. Unlike prior studies, the methods used in this study focused on acquisition
modification rather than retrospective analysis.

I. The Patient Sample
With the approval of The University of Texas MD Anderson Cancer Center
institutional review board (protocol 2011-0631), the first phase of this study
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involved 18 patients scheduled to receive thoracic radiation therapy. The patients
(eight women and 10 men) had clinical diagnoses of non-small cell lung cancer
(N=12), esophageal cancer (N=4), or mesothelioma (N=2). The mean (±standard
deviation [SD]) age of study participants was 66.3±10.1 years. Each patient
received a standard simulation 4D CT scan, immediately followed by each of the
three experimental acquisition methods.

II. 4D CT Parameters
All 4D CT images were acquired in cine mode on a GE Discovery ST PET/CT
scanner (GE Medical Systems, Waukesha, WI) with a 500 ms tube rotation time;
the CT component is an 8-slice Lightspeed CT. A real-time processing monitor
(RPM; Varian Associates, Palo Alto, CA) served as an external surrogate for organ
motion. This provided a respiratory trace of relative abdominal height versus time.
The acquisition time per couch position (cine duration) was based on the patient’s
average breathing cycle plus 1 s. This acquisition over the patient’s breathing cycle
yields several multi-slice image segments (8×2.5 mm axial images) per couch
position. Images were reconstructed by using 360° of data (full reconstruction) with
a cine time between images ranging from 350 ms to 450 ms. Scans were obtained at
120 kVp, with a 100 mA tube current for the clinical acquisitions and a dosesparing 50 mA for the experimental acquisitions. The tube current reduction for the
experimental acquisitions was deemed appropriate due to the large increase in the
total imaging dose from the additional scans and the minimal effect that the
reduction in the beam current would have on the image quality. (78)
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III. Experimental Methods
i) Gating Method
To implement the gating method (GM), we monitored the respiratory trace in
real time to facilitate manual beam gating when an apparent breathing irregularity
occurred, and we subsequently restarted the beam when regular breathing
returned. Manually stopping the beam caused the entire couch position to repeat
to ensure that at least one breathing cycle was acquired per couch position; this
yielded a full 4D CT image set plus gated sections.

ii) Rescan Method
For the rescan method (RM), image segments were re-acquired at identified
locations at which breathing irregularities occurred during the clinical acquisition.
Implementation of the RM involved immediate post-processing of the clinical 4D
CT respiratory trace to identify the couch positions where images were to be reacquired. Only the identified couch positions were rescanned and replaced in the
clinical 4D CT for the final RM image set.

iii) Oversampling Method
For the oversampling method (OM), the beam-on time was increased to
capture two breathing cycles per couch position, or approximately double the data
of the clinical scan; therefore the clinical cine duration was increased by a factor
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of two unless the patient’s breathing had changed. This was implemented by
altering the manufacturer’s internal constraint for data acquisition from 3000 to
6000 images to allow for extended cine durations.

iv) Breathing Irregularity Detection
To identify breathing irregularities, we defined a tolerance range that was
based on the mean and standard deviation of the 10 phase amplitudes across the
scan extent. A phase was considered irregular when the amplitude fell out of the
range given by mean amplitude ±1 standard deviation. A couch position
warranted repeat imaging if 30% or more of the location was associated with
irregularities. This threshold was chosen based on an average of 15 image
segments per couch position; if 30% or more of the segments are irregular, then
the final phase image set will contain segments associated with an irregularity that
is likely to be present as an artifact. An example of an irregular T0% phase in a
patient respiratory trace is shown in Figure 2.2. Breathing irregularities were
calculated retrospectively in all 4D CT acquisitions. This method of irregularity
detection is been outlined in Chapter 2 section I.

v) Acquisition Order
The clinical acquisition was always done before the experimental scans;
because the RM combined data from an independent scan into the clinical scan,
this method was always performed immediately after the clinical scan to
minimize any changes in breathing or internal and external anatomic shifts. Either
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the OM or GM followed the RM; these were alternated in an attempt to offset any
detrimental effect from the end of the exam acquisition. A normal inhalation
breath-hold was taken as an inhalation breath-hold as close to the patient’s normal
T0% maximum inhalation as possible. A deep inspiration breath-hold is the
clinical standard, but a deep inspiration breath-hold exaggerates the inhaled
anatomic state. This yields a larger vector magnitude between identical anatomy
from the normal inhalation T0% and from the deep inspiration breath-hold; the
normal inhalation breath-hold yields a smaller vector magnitude from the T0%.(79,
80)

IV. Post-Processing Methods
ii) Phase Sorting
Each acquisition method was processed in two ways: by phase sorting and by
a quantitative image correlation-based sorting method. The T0% phases were
defined by selecting the maximum inhalation peaks on the RPM respiratory trace;
the subsequent breathing phases were defined as percentages of the breathing
period in 10% increments, i.e. T0%, T10%, T20%, etc. The clinical standard
sorting method is phase sorting, as outlined in Chapter 1. Custom MATLAB (The
MathWorks, Inc., Natick, MA) software was created for phase sorting of clinical
and experimental acquisitions. The GE Advantage Workstation is used for phase
sorting 4D CT scans that will be used in treatment planning. We processed our
clinical acquisitions by using our custom software to ensure that the protocol
clinical acquisitions and experimental acquisitions could be compared accurately
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without differences from software implementations adversely affecting the
results.
A few minor differences in phase sorting exist between our software and the
GE software: the GE software modifies the phase definitions to occur directly at
RPM samples (the RPM sampling period is approximately 33.4 ms) and the first
of two image segments is chosen when the two segments occur an equal time
distance from a defined phase. The former difference may result in one or two of
GE-generated couch positions containing different image segments than our
custom sorted scans because of a potential difference in the phase definition of up
to 17 ms. Retention of the exact percentage of each breathing cycle period for
phase definitions results in more accurate image sorting. The latter difference
typically only would affect the image segment chosen for one couch position, but
this situation is very rare and does not occur for many patients or breathing
phases.

ii) Experimental Sorting
The experimental sorting method is an expansion of phase sorting: instead of
choosing the nearest neighbor image segment to a phase, multiple image segments
are chosen and an optimal combination is determined by minimization of the
artifact metric (Eqn. 3), as validated in Chapter 2. The breathing phases are
defined the same as in phase sorting. The three closest image segments in time to
the phase definitions were binned; this allowed retention of breathing information
with potential for artifact reduction in the available data. The absolute value of the
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sum of the correlation metric (CM) values across all of the couch positions was
minimized by using the shortest path Dijkstra’s algorithm.

(30, 31)

This sorting

method is referred to as CM sorting. Custom MATLAB (The MathWorks, Inc.,
Natick, MA) software was developed for this experimental sorting method.

V. Artifact Evaluation
i) Artifact Analysis
The CM provided quantitative-based rankings of scan methods per patient per
sorting technique. The sum of the absolute value of CM values was calculated for
each component phase image set of each acquisition method for each sorting
method, and rankings were derived from the mean of the summed CM values over
the phases. A rank (1-4) was assigned to each method per patient, with increasing
rank corresponding to increasing averaged CM value and poorer image quality.
The images were visually assessed to verify the rankings.

ii) Statistical Analysis
Statistical analysis of the average CM values used one-way mixed ANOVA
with heteroscedastic variance by acquisition method. An F-test was used to test
for association between acquisition methods. Pairwise comparisons among the
four acquisition methods used simultaneous inference with Tukey's method. The
familywise error rate was controlled at the 0.05 significance level. Tukey’s
adjusted, a two-sided p-values are reported. Interval estimation of the percentage
reduction in CM values for CM sorting relative to phase sorting averaged over
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acquisition method and phase is provided with two-sided 95% confidence
intervals.

VI. Effective Dose Estimates
The estimated effective dose delivered to each patient using each of the 4
acquisition methods was also calculated, adjusting for clinical tube current and
clinical acquisition extent in the experimental methods for accurate comparison
with the standard clinical acquisition. Dose estimates were derived from the CTDI
method(81, 82) based on a measured CTDIvol of 50 mGy(32) for a cine duration of 5.6
seconds, and a tube current of 100 mA with a k-factor for an adult chest of 0.014
mSv/mGy-cm(81, 83, 84).

VII. Artifact Presence vs Breathing Irregularities
The presence of artifacts as indicated by mean CM values over the phases was
correlated with the number and percentage of irregular breathing phases over the
scan extent to determine whether an overall poor image quality corresponded to
overall poor breathing regularity in clinical and oversampling phase-sorted and
CM-sorted acquisitions. The number of breathing irregularities was also correlated
with the percentage of GM acquisition duration compared with the clinical
acquisition, to determine whether longer scan times were required because of highly
irregular breathing. Pearson correlation coefficients were used in these calculations.

RESULTS
I. Patient Summary Statistics
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The mean percentage of breathing irregularities present during image
acquisition for all 72 4D CT scans was 28.0±7.7%.

Respiratory trace parameters

derived over the scan extent included a mean displacement from inhalation to
exhalation of 0.98±0.41 cm, and an average breathing period of 4.34±1.3 seconds.
The mean percentage of the re-acquired scan extent for the RM was 40.3±10.0%; a
mean of 37.8±18.1% of the images were re-acquired in the lung. A mean of
28.4±11.2% of breathing irregularities occurred during the re-acquisition of images
for the RM. A mean of 54.6±12.1% of breathing irregularities were not gated
during the GM image acquisition, which is a 26.7% reduction from the clinical
acquired irregularities. The GM led to a 66.7±39.2% increase in acquisition time
compared with the clinical 4D CT acquisition time; this was due to the couch
repetition for each beam stop and the time intervals between x-ray beam on during
irregular breathing. Automatic x-ray beam control and acquisition of only one cine
duration per couch position would decrease this prolonged extension of the scan
duration. Despite the increase in scan duration, all clinical and experimental 4D CT
scans were acquired within the standard clinical 60-minute time slot.

II. Experimental Acquisition Rankings
i) Phase-Sorted Acquisitions
Among phase-sorted acquisition methods (Figure 3.1) the GM and the
clinical ranked highest (each N=8), followed by the OM (N=2).
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Figure 3.1. Phase-Sorted Acquisition Rankings. Distribution of rankings for the phasesorted 4D CT methods for the 18 patients. Rank=1, blue bars, 1st from left; Rank=2, red
bars, 2nd from left; Rank=3, green bars, 3rd from left; Rank=4, purple bars, 4th from left

ii) CM-Sorted Acquisitions
Among CM-sorted acquisition methods (Figure 3.2) the OM ranked highest
(N=9), followed by the GM (N=5), and the clinical (N=4). Sample coronal
images comparing the CM-sorted acquisition methods (Figure 3.3) and
comparing the sorting methods (Figure 3.4) are provided.
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Figure 3.2. CM-Sorted Acquisition Rankings. Distribution of rankings for the CMsorted 4D CT methods for the 18 patients.
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Figure 3.3. CM-Sorted Sample Coronal Views.

Figure 3.4. Sample Coronal Views for Sorting Comparison. Phase-sorted (left) and
CM-sorted (right) clinical acquisition sample coronal views.
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III. Statistical Analysis
i)

Phase-Sorted Acquisitions
Significant differences were evident among the acquisition methods
(p<0.024). The mean CM values for the RM indicated a 30% increase in
artifact presence relative to the clinical acquisition (p<0.001). The data
lacked evidence of a significant difference among clinical, GM, and OM
acquisitions.

ii)

CM-Sorted Acquisitions
Significant differences were evident among the acquisition methods
test for CM sorting (p<0.0001, F-test). The mean CM values for the RM
indicated an increase in artifact presence relative to the clinical acquisition
(37%; p<0.002), the GM (26%;p<0.0052), and OM (31%;p<0.001). The
data lacked evidence of a significant difference among clinical, GM, and
OM acquisitions using CM sorting.

iii)

CM vs Phase Sorting
CM sorting resulted in an estimated 24% reduction from phase sorting
in mean CM (95% confidence interval=27-22). CM sorting applied to the
OM resulted in a 27% reduction from the clinical standard of phase sorting
applied to the clinical acquisition (95% confidence interval=34-20).
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IV. Effective Dose Estimates
Figure 3.5 displays the estimated effective doses that were received by each
patient for each acquisition method, with an adjustment for clinical tube current
(100 mA) and clinical scan extent to the experimental acquisitions for proper dose
comparison among all acquisition methods. The mean effective dose for the clinical
method was 32.2±5.4mSv, the gating method was 37.0±8.4mSv, rescan method was
43.5±7.4mSv, and oversampling method was 64.8±11.8mSv. All experimental 4D
CT acquisition methods, if applied clinically, would impart higher effective doses
than the standard clinical 4D CT; the GM would impart the smallest dose increase
and the OM would impart the largest dose increase.

Figure 3.5. Estimated Cohort 1 Comparable Effective Doses. Effective doses
with clinical tube current and clinical scan extent adjustment to experimental
methods. The means of the dose estimates are shown in the legend.
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V. Breathing Irregularities vs Artifact Presence
The relationship between the number of irregular breathing phases across the
scan extent and the mean CM values are displayed for phase-sorted clinical and
oversampling acquisitions (Figure 3.6), and for CM-sorted clinical and
oversampling acquisitions (Figure 3.7) with the Pearson correlation coefficient
shown in the upper right corners. Correlations between the phase-sorted (Figure
3.8) and CM-sorted (Figure 3.9) mean CM values versus percentage of breathing
irregularities, and between the number of irregularities versus GM acquisition
duration increase (Figure 3.10) are displayed below.

Figure 3.6. Phase-Sorted Artifacts vs Number of Breathing Irregularities.
Artifact presence in phase-sorted clinical and oversampling acquisitions, as defined
by the mean CM values over component breathing phases, versus the number of
breathing irregularities present during the scan extent. Pearson correlation
coefficient is given by r in the upper right corner.
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Figure 3.7. CM-Sorted Artifacts vs Number of Breathing Irregularities.
Artifact presence in CM-sorted clinical and oversampling acquisitions, as defined
by the mean CM values over component breathing phases, versus the number of
breathing irregularities present during the scan extent. Pearson correlation
coefficient is given by r in the upper right corner.
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Figure 3.8. Phase-Sorted Artifacts vs Percentage of Breathing Irregularities.
Artifact presence in phase-sorted clinical and oversampling acquisitions, as defined
by the mean CM values over component breathing phases, versus the percentage of
breathing irregularities present during the scan extent. Pearson correlation
coefficient is given by r in the upper right corner.
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Figure 3.9. CM-Sorted
Sorted Artifacts vs Percentage of Breathing Irregularities.
Artifact presence in CM
CM-sorted
sorted clinical and oversampling acquisitions, as defined
by the mean CM values over component breathing phases
phases, versus the percentage of
breathing irregularities present during the scan extent. Pearson correlation
coefficient is ggiven by r in the upper right corner.
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Figure 3.10. Gating Scan Duration vs Breathing Irregularities. Number of
breathing irregularities versus percentage of GM beam-on time compared with the
clinical acquisition beam-on time.

DISCUSSION
All CM-sorted acquisitions demonstrated a significant reduction in CM values from
their phase-sorted equivalent, indicating that CM sorting produces superior image quality
over phase sorting. Because we optimized an artifact-evaluating metric (CM) on possible
image combinations per phase, we were able to minimize the presence of artifacts while
retaining breathing information. This is consistent with previous findings from
correlation-based image processing techniques.(28,

59, 85, 86)

This is the first study to

demonstrate improvement in a prospective setting.
The CM-sorted OM achieved the greatest significant artifact reduction of 27%
compared with the clinical acquisition with phase sorting. The OM contained the lowest
artifact presence among CM-sorted acquisitions, but ranked poorly among phase-sorted
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acquisitions. Phase sorting is limited because images are selected based on their distance
in time to the phase definitions and do not incorporate image information for matching
the anatomy, so the data increase in the OM may not have been fully used. Of all the
experimental acquisition methods tested, the OM was the simplest to implement but also
delivered the highest dose of all of the 4D CT acquisition methods tested.
The GM ranked well with phase sorting and moderately with CM sorting, but the
artifact reduction was not significantly reduced relative to the clinical acquisition and the
GM was roughly equal in image quality to the clinical acquisition for both sorting
methods. More accurate detection of breathing irregularities and automatic x-ray beam
control may improve this acquisition method. Because the respiratory trace could not be
adequately viewed in its entirety in real time, only the last few cycles of the current
breath determined the visual detection of an irregularity. A temporal lag also existed
between the verbal indication to the operator to control the beam and the ensuing manual
operation at the scanner by the operator. These factors led to a mean 54.6% of breathing
irregularities that were not gated during image acquisition, which is a 26.7% reduction in
acquired breathing irregularities relative to the clinical acquisition. Although more
irregularities could have been gated, a larger artifact reduction was expected given the
27% reduction in acquired irregularities. A more robust irregularity quantification may be
needed. It is also possible that the correlation between the breathing irregularities and the
overall scan quality may not be as strong as previously thought, as indicated by the lack
of correlation between mean CM values and irregularities (Results, section V). This lack
of correlation indicated in there could be from a poor RPM correlation with internal
anatomy, lack of a more robust irregularity detection method, or lack of an overall strong
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correlation due to the averaging effects of higher and lesser magnitude artifacts within the
4D CT.
Stopping the beam for irregularities and waiting until regular breathing resumed
increased the total scan duration. This was exacerbated by the couch position repetition in
this implementation; leading to a mean 66.7% longer scan duration compared with the
clinical acquisition. The scan duration seemed to be moderately correlated with the
number of irregularities across the scan duration; this was expected, because more time is
needed to acquire regular breathing for a patient with more irregular breaths. The GM
acquisition duration would likely decrease with automatic control over the x-ray beam
and evaluation of the real-time respiratory trace to determine when a full cycle of data
had been acquired. However, even with this increase, all experimental and clinical 4D CT
scans that were necessary for treatment simulation were obtained within the standard 60minute clinical time slot.
The RM contained the greatest artifact presence of all the acquisitions and processing
methods, and was significantly poorer than the clinical acquisition for both processing
methods. The RM suffered from combining two independent data sets, and from not
gating irregularities in the re-acquired images. The mean percentage of irregular
breathing phases that occurred during the RM image re-acquisition was 28.4%. To
evaluate the anatomical shifts present in the RM, the T0% phase of the RM was fused
with the T0% phase of the clinical 4D CT for each patient. One of the 18 patients
experienced a significant bone shift between the clinical 4D CT and RM, but most
anatomical shifts were internal. Image segments were repeated without bias to scan
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location, resulting in a mean of 37.8% of the re-acquired extent occurring in lung, with as
few as a single couch position repetition in the lung.
The OM delivered at least twice the dose of that delivered by the clinical 4D CT
method because of the increase in the cine duration needed to capture two cycles of
breathing data. The RM delivered the second highest dose because a full clinical 4D CT
was required in addition to the re-acquired images. The dose delivered with the RM could
be reduced if the re-acquired couch positions were limited to those covering the lung. The
GM delivered a dose equal to at least one clinical 4D CT scan because of the couch
repetition inherent in the manual gating process, but the GM delivered the lowest overall
effective dose of all the experimental methods tested. The effective dose delivered by the
GM could be reduced by the exclusion of the couch repetition.
Because phase sorting selects image segments based on time, the images chosen
could contain poor-quality data leaving the extra data available in the OM either not or
only partially utilized. The CM sorting selects images based on time to phase in
conjunction with spatial distributions present in the images, which opens the data
selection to a potentially more accurate representation of breathing states. Because CMsorted oversampling achieved the greatest reduction in artifact presence relative to the
clinical standard, and because the OM has a simple and reproducible implementation, we
consider it to be the best acquisition and sorting combination.
Although our study includes retrospective analysis of the two sorting methods, the
focus was on alternative acquisition techniques, as these are lacking in the literature.(32, 3537, 44)

We performed these acquisitions on a relatively large number of patients, without

the use of simulations or phantoms.(31,

39, 67)

Artifacts were evaluated based on
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quantitative assessments of the images, relying on a validation of the metric(56, 87) and a
general agreement with visual observation. The metric does not correlate exactly to visual
assessment, but it provided a consistent method for evaluating scans in a relative fashion.
Another implementation weakness in this study is that the patients had to remain on
the CT table in treatment position for at least 20 minutes longer than is needed for routine
clinical scans while the experimental scans were acquired. To reduce anatomic shifts, the
RM was acquired immediately after the clinical scan followed by the OM or GM, which
were alternated from one patient to the next. Patients often became tired or uncomfortable
with the longer scan times and the most promising scans were performed during the
patient’s worst state. Therefore we expect the scan quality to improve further if these
methods are performed closer to when the patient first lies down on the table.

CONCLUSIONS
Artifact presence in the clinical 4D CT acquisition was compared with that in three
experimental acquisition methods: data oversampling, beam-gating the breathing
irregularities, and rescanning the clinical scan areas that were acquired during irregular
breathing. Each was post-processed by the clinical standard phase sorting and by an
alternative sorting method (CM sorting) that optimizes a correlation-based artifact metric.
This alternative sorting method was found to significantly reduce artifact presence by
approximately 24% across all acquisition methods. The oversampling acquisition
combined with the alternative sorting method produced the highest statistically
significant artifact reduction relative to the standard of phase-sorted clinical acquisition
and was the simplest and most reproducible to implement.
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CHAPTER 4
BEST 4D CT METHOD REPRODUCIBILITY

INTRODUCTION
The MD Anderson-approved protocol 2011-0631 included two patient cohorts; the
first cohort of 18 patients was tested as described in Chapter 3 to determine the best 4D
CT method, i.e., that which contained the lowest overall artifact presence. The objective
for the second cohort was to determine the reproducibility of the identified best 4D CT
method, and determine whether this best-chosen method consistently performs well
across a broad patient sample when repeated. This Chapter describes our methods to test
the reproducibility of the best-chosen 4D CT method, the CM-sorted oversampling
acquisition (OCM).

I. The Patient Sample
The second cohort was comprised of 10 patients scheduled to undergo radiation
therapy; half of the patients were women and half were men, and all had a clinical
diagnosis of primary non-small cell lung cancer. The mean age of the participants
was 68 ± 13.7 years. Each patient received a clinical 4D CT scan immediately
followed by the chosen improved 4D CT method, which was repeated twice.

II. Improved Experimental Method
Each patient received a clinical phase-sorted 4D CT scan immediately followed
by the three acquisitions of the improved experimental 4D CT method, termed
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OCM1, OCM2, and OCM3 for each oversampling scan performed in chronologic
order with CM sorting applied. After these four 4D CT scans, a normal-inhalation
breath hold scan was acquired to serve as an anatomic reference. Not all patients
could perform a stable normal inhalation breath hold and in those cases a deep
inhalation breath hold was acquired. The OCM was performed as outlined in
Chapter 3 (section III. iii), with a tube current of 50 mA in an effort to reduce the
dose to the patient while maintaining acceptable image quality for the study. The
scan extent was reduced from the clinical scan extent when possible to further
reduce dose received by the patient. All other 4D CT acquisition parameters are the
same as those outlined in Chapter 3 (section II).

III. Analysis
i)

Artifact Presence
Statistical analysis consisted of a one-way mixed ANOVA to account for

intra-patient correlation among the CM values across multiple phases. An F-test
was used to test for an association with acquisition method and repetition. The
resulting two-sided 95% confidence intervals are provided for each replicate scan
for the percentage reduction in mean CM values for the OCM versus the clinical
method. Inter-acquisition variability in CM values (inter-replicate deviation) was
assessed by using the three independent acquisitions of oversampling in this
sample of 10 patients. The resulting 95% limits of agreement were estimated using
one-way mixed effects ANOVA.
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ii)

Image Quality vs. Patient Parameters
Given the wide range of percentage artifact improvement across patients, we

explored possible relationships between image quality, patient characteristics, and
breathing parameters. The CM values for the phase-sorted clinical method and
OCM as well as the percentage improvement in OCM from the clinical method
were used as the image quality parameters. Spearman correlation coefficients were
calculated between all parameters. The Wilcoxon rank sum was used to test for
significant differences between median CM values and the sex of the patient.
Linear mixed regression was used to model the association between artifact
presence and other variables. All tests were two-sided and p-values of 0.05 or less
were considered statistically significant. Statistical analysis was carried out using
SAS version 9.3 (SAS Institute, Cary, NC).

IV. Effective Dose Estimates
Effective dose estimates were calculated as outlined in Chapter 3 section VI. The
estimated doses reported include an adjusted tube current (100 mA instead of 50 mA)
and scan extent in the calculation to match the clinical values for appropriate
comparison of experimental acquisitions to the clinical acquisition.

RESULTS
I. Patient Respiratory Statistics
Table 4.1 displays the summary statistics derived from the respiratory traces of
the second cohort of patients. These statistics include percentage breathing
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irregularities, mean abdominal displacement, mean breathing period, and mean
number of breathing cycles per beam-on indicating the amount of data acquired at
each couch position.

Acquisition
Type

%
Breathing
Irregularities

Mean
Displacement
(cm)

Mean
Breathing
Period (s)

Mean
Breathing
Cycles/ BeamOn

Clinical

31.3 ± 7.15

0.897 ± 0.361

4.78 ± 1.54

1.49 ± 0.304

OCM1

25.4 ± 6.79

0.771 ± 0.302

4.43 ± 1.17

3.03 ± 0.599

OCM2

26.8 ± 5.80

0.834 ± 0.396

4.72 ± 1.72

2.86 ± 0.645

OCM3
30.0 ± 5.84
0.783 ± 0.299
4.60 ± 1.39
2.93 ± 0.646
Table 4.1. Cohort 2 Patient Respiratory Statistics. Percentage of breathing
irregularities, mean displacement between peak exhalation and peak inhalation,
mean breathing period, and mean breathing cycles per beam-on. All parameters
were calculated over the scan extent.

II. Analysis of Artifact Presence
Significant differences were evident among the clinical and OCM methods
(p<0.0001, F-test). The OCM resulted in an estimated 28% reduction in CM values
from the clinical method (95% confidence interval = 20% - 37%; Figure 4.1). The
inter-replicate deviation for the OCM 4D CT scans was within approximately
±13% of the cross acquisition average at the 0.05 significance level (Figure 4.2).(88,
89)

Figure 4.3 demonstrates the spread of CM values per breathing phase over each

acquisition method per cohort 2 patients. Examples of coronal views of the clinical
phase-sorted 4D CT and the three subsequent oversampling CM-sorted 4D CT
scans are given in Figure 4.4.
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Figure 4.1. Boxplot of CM Values by Acquisition Method. The sum of the
absolute value of the CM values over all couch positions per breathing phase per
acquisition method.
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Figure 4.2. Bland-Altman Plot for Oversampling CM Value Inter-Acquisition
Agreement. Observed and expected percentage deviation from the mean CM
values under the three oversampling acquisitions. One-way mixed effects ANOVA
obtains 95% confidence boundaries = ±13%.
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Figure 4.3. CM Value Spread per Patient. Spread of CM values per breathing
phase over all acquisitions per patient.
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Figure 4.4. Coronal views of the clinical and repeat OCM scans. Sample
images from the clinical phase-sorted method (CPS), and three CM-sorted
oversampling scans (OCM1, OCM2, OCM3) from a patient case.

III. Image Quality vs. Patient Parameters
Spearman correlation coefficients between CM values and breathing
parameters are given in Table 4.2. Breathing parameters include means over the
scan extent: breathing cycles per couch position (amount of data collected),
breathing period, abdominal displacement, percentage breathing irregularities, and
number of breathing irregularities. Spearman correlation between percentage
improvement in CM values for OCM from phase-sorted clinical CM values and
breathing parameters are given in Table 4.3.
A Wilcoxon rank sum test was performed to evaluate the significance of
association of image quality with patient sex. Percentage improvement from
clinical to the OCM did not associate significantly with sex, however CM values
for both methods were significantly associated (clinical median CM values (F/M)
= 0.013/0.017; p-value<0.007, OCM median CM values (F/M) = 0.009/0.012; pvalue<0.005) with men demonstrating higher artifact presence generally. Results
of the mixed regression analysis for association with percentage improvement in
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CM values indicated a significant association with age (p-value< 0.035), indicating
that older patients experienced greater improvement from the OCM. Significant
correlations between improvement in image quality and OCM, breathing period,
age, and amount of data are demonstrated in Figure 4.5.

4D CT Method

Cycles/Couch PER

DIS

%IRREG IRREG

-0.365
0.407 0.239
-0.108
-0.213
Clinical CM Values ρ
0.057
0.032 0.221
0.585
0.276
(N=28)
p-value
-0.0740
-0.148
-0.270
-0.335
0.296
ρ
OCM CM Values
0.020
0.041 0.616
0.315
0.063
(N=48)
p-value
Table 4.2. Spearman correlation coefficients between CM values and
breathing parameters.
Cycles/Couch = breathing cycles per couch position; PER = breathing period; DIS
= abdominal displacement; %IRREG = percentage breathing irregularities; IRREG
= number of breathing irregularities

% Difference from clinical oversampling
% CM
Improvement Cycles/Couch
PER
DIS
%IRREG IRREG
0.490
0.375
0.177
-0.150
-0.215
ρ
0.0004
0.009
0.228
0.308
0.142
p-value
Table 4.3. Spearman correlation coefficient between percentage improvement
in CM values with OCM and percentage difference in breathing parameters.
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Figure 4.5. Significant patient parameters indicative of image quality.
Percentage improvement with OCM versus percentage difference in breathing
cycles per couch position (left), percentage difference in breathing period (middle),
and age (right).

IV. Effective Dose Estimates
Figure 4.6 displays the estimated effective doses that were received by each
patient in the second cohort for each 4D CT acquisition
acquisition,, with an adjustment for
clinical tube current (100 mA) and clinical scan extent to the OM scans for proper
dose comparison with the cclinical dose received.. The mean of the effective dose for
the clinical method was 331.5±4.3 mSv, for the first OM scan, it was 60.4±8.6
60
mSv,
for the second OM scan, 59
59.4±9.8 mSv, and for the third OM scan, 60.1±9.5
60
mSv.
All OM acquisitions,, if applied clin
clinically, would impart approximately twice the
effective dose of the standard clinical 4D CT.
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Figure 4.6 Estimated Comparable Effective Doses for Cohort 2. Estimated
effective doses (mSv) received per 4D CT acquisition for the 10 patients in cohort
2. Effective
ctive doses for oversampling scans (O1, O2, O3) include clinical tube
current and scan extent settings.

DISCUSSION
A significant reduction in artifacts relative to the clinical phase-sorted
sorted 4D CT was
again reached with the CM--sorted oversampling method for the second patient cohort.
The estimated artifact reduction based on CM values was 28%, a 1% improvement from
the 27% reduction achieved with the first patient co
cohort.
hort. This finding indicates that the
CM-sorted
sorted oversampling 4D CT method was consistent among a larger patient sample.
The inter-replicate
replicate deviation for the repeated OCM scans was 13%; this is fairly tight,
especially considering the outlier cases, patien
patients
ts six and 10. These outliers result in part
from a patient effect, in which certain patients generally have higher CM values for any
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acquisition specific to them, and they are also reflect irregular breathing that caused high
magnitude artifacts that dramatically decreased the overall quality of the scan. These
patients generally experienced a larger percentage improvement in artifact presence with
the OCM because the image-guided sorting and extra available data allowed avoidance of
the image segments that were acquired during irregular breathing. The OCM estimated
effective doses are consistent, varying slightly because of changes in cine duration, and
are roughly double the dose of the clinical acquisition.
Several statistically significant associations between artifact presence (CM values)
and patient parameters were found, although the strength of the correlation was moderate
at best. Higher numbers of breathing cycles per couch position yielded lower CM values
(fewer artifacts) for the OCM, whereas shorter breathing periods yielded fewer artifacts
for both clinical and OCM methods, and women tended to have fewer artifacts than men
for both methods. We are unsure why women’s images would exhibit less artifacts than
men’s images, a possible explanation is a difference in chest and abdominal breathing
distribution between sexes, or perhaps multiple factors pertaining to the patient’s health
are present. A higher percentage improvement with the OCM 4D CT was significantly
correlated with patient age, breathing period, and breathing cycles acquired per couch
position.
In general, the older patients experienced more improvement with the OCM 4D CT
than younger patients, although no significant correlation was noted between age and CM
values. This may reflect an increased discomfort experienced by the older patients during
the scan session, resulting in more variable breathing; the image-guided CM-sorting and
additional available data in the oversampling allow more accurate images to be chosen in
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these situations. This would not be reflected well in our irregularity quantification, which
did not significantly correlate with image quality, although various reports cite the
negative effect of breathing irregularities on image quality (as cited in the introduction to
Chapter 2. The irregularity quantification calculated does not characterize all of the
points in the respiratory trace, just 10 points of the 150 points present during a 5 s
breathing period. Another issue with the breathing quantification is the lack of a reference
trace or relative parameter indicative of quality across multiple scans per patient. Each
scan’s irregularities are identified as irregular with regard to that particular scan’s
respiratory trace; this makes it difficult to compare irregularities present across multiple
scans per patient.
Patients with faster breathing (i.e., a shorter breathing period) tended to have less
artifact presence in their clinical and OCM 4D CT scans, as well as a higher percentage
improvement with the OCM scans. This may be from smaller motion experienced with
shorter breaths, or from an increase in breathing cycles per couch position collected
because of the faster breathing. There was a significant correlation between breathing
period and breathing cycles per couch position for the clinical and OCM methods (-0.91,
p-value<0.0001 clinical, -0.618, p-value<0.0005 OCM) indicating that the amount of data
that are collected may be driving the correlation with the breathing period. An increase in
breathing cycles per couch position reflects the amount of data acquired, and the more
data collected, the fewer the artifacts with image-guided sorting. Phase sorting is limited
to selecting image segments solely based on time, and therefore does not show an
improvement in image quality with added data; the data may be there, but are not being
used.
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Patient sex was significantly correlated with artifact presence in both 4D CT
methods, with 4D CT scans for women having lower CM values than for men. This may
reflect an inherent difference in breathing between men and women that was reflected in
our evaluation of image quality. Differences in breathing through the nose or mouth have
been reported to affect breathing variability for both men and women, albeit in different
manners.(90) It has been reported that men tend to experience a larger AP abdominal
displacement during quiet breathing(91) as well as larger abdominal displacements during
deep breathing.(92) There are many factors that affect breathing characteristics for both sex
and age, and these correlations were moderate at best, so these non-zero correlations may
also reflect other anatomic parameters or medical issues not explored in this work.
Yamamoto et al.(26) evaluated correlations between similar parameters and
visually identified artifacts, and found significant correlations between image quality,
abdominal displacement, and breathing period. We also experienced a significant
correlation with breathing period, but the correlation values in the Yamamoto study were
not reported, and a moderate correlation may also have been present. Their correlation
was not based on an overall measure of image quality however, but on a fraction of cases
evaluated that contained any artifact at all. We did not calculate a significant correlation
between abdominal displacement and artifact presence for either 4D CT method. Because
the image sampling and number of available image segments depends on time and the
motion happening within that time, perhaps the artifact presence is related more to the
period than the displacement.

CONCLUSION
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A second cohort of 10 patients with primary thoracic cancer was used to test the
reproducibility of the artifact reduction achieved with the CM-sorted oversampling 4D
CT method. The oversampling method achieved a 28% artifact reduction compared with
the clinical method, a 1% difference from the first cohort, and demonstrated a low interreplicate deviation. Therefore the CM-sorted oversampling 4D CT method consistently
and significantly reduced the artifact presence relative to the clinical phase-sorted
standard. In general, larger reductions in artifacts with the improved method were
obtained for patients who breathed more quickly, were more elderly, and had scans with
greater amounts of data collected.
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